Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

I Monnet, S Brienza, F Hugret, S Voisin, J Gastiaburu, J.C Saltiel, P Soulié, J.P Armand, E Cvitkovic, H de Cremoux

Open source

DOI: 10.1016/s0959-8049(98)00007-0
Published: 1998-06
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0959-8049-98-00007-0,
  title = {Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)},
  author = {I Monnet and S Brienza and F Hugret and S Voisin and J Gastiaburu and J.C Saltiel and P Soulié and J.P Armand and E Cvitkovic and H de Cremoux},
  year = {1998},
  journal = {European Journal of Cancer},
  doi = {10.1016/s0959-8049(98)00007-0},
  url = {https://doi.org/10.1016/s0959-8049(98)00007-0}
}

RIS

TY  - JOUR
TI  - Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
AU  - I Monnet
AU  - S Brienza
AU  - F Hugret
AU  - S Voisin
AU  - J Gastiaburu
AU  - J.C Saltiel
AU  - P Soulié
AU  - J.P Armand
AU  - E Cvitkovic
AU  - H de Cremoux
PY  - 1998
JO  - European Journal of Cancer
DO  - 10.1016/s0959-8049(98)00007-0
UR  - https://doi.org/10.1016/s0959-8049(98)00007-0
ER  -

APA

Monnet, I., Brienza, S., Hugret, F., Voisin, S., Gastiaburu, J., Saltiel, J., Soulié, P., Armand, J., Cvitkovic, E., & Cremoux, H. D. (1998). Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). European Journal of Cancer. https://doi.org/10.1016/s0959-8049(98)00007-0

Source records

crossref · retrieved 2026-09-25T11:43:01.302Z